About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in San Antonio | 47 Studies

Clinical Trials Multiple SclerosisSan Antonio

Multiple Sclerosis Clinical Trials in San Antonio

Find 47 clinical trials for multiple sclerosis near San Antonio, Texas. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 47 trials

CompletedA Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple SclerosisThis randomized, double-blind, double-dummy, parallel-group study will evaluate the efficacy and safety of ocrelizumab in comparison with interferon beta-1a (Rebif) in…NCT01412333·Phoenix, Arizona and 164 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension PhaseThis study assessed the safety, tolerability, and efficacy of 2 doses of oral fingolimod versus interferon β-1a to reduce the frequency of relapses in patients with…NCT00340834·Cullman, Alabama and 169 others

CompletedAcute Effects of Whole-body Vibration Training in Hypoxia and Normoxia in Multiple Sclerosis PatientsMultiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and…NCT03856801·Murcia

CompletedEffects of Ten-Weeks Progressive Resistance Training on Neuromuscular Performance, Mobility, Heart Rate Variability and Sleep Quality in Persons With Multiple SclerosisMultiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and…NCT04452760·Murcia

Active not recruitingComparison Between ABP 692 and Ocrevus® (Ocrelizumab)The Main objectives of the study are to demonstrate pharmacokinetic (PK) similarity between ABP 692 and ocrelizumab (US), as well as between ABP 692 and ocrelizumab (EU).NCT06700343·Mobile, Alabama and 108 others

Active not recruitingEfficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisThe purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the…NCT06141486·Homewood, Alabama and 310 others

CompletedNonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMS Secondary Objective: To evaluate efficacy of…NCT04411641·Birmingham, Alabama and 305 others

CompletedPrimary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)Primary Objective: To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple sclerosis (PPMS) Secondary…NCT04458051·La Jolla, California and 276 others

RecruitingNon-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisThis is a randomized, open-label, parallel, Phase 3 study with 2-arms for treatment.NCT07325292·Cullman, Alabama and 67 others

CompletedPatient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®The purpose of this study is to evaluate the proportion of patients who demonstrate no medical need to discontinue therapy among DMT-naïve patients with relapsing forms of…NCT02823951·Birmingham, Alabama and 22 others

CompletedComparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study TwoThe purpose of this study was to establish the efficacy and safety of two different doses of alemtuzumab (Lemtrada™) as a treatment for relapsing-remitting multiple sclerosis…NCT00548405·Cullman, Alabama and 190 others

Active not recruitingA Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or…NCT06372145·Birmingham, Alabama and 351 others

CompletedA Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple SclerosisThis is a Phase II, randomized, double-blind, parallel group, placebo controlled, multicenter study to evaluate the safety and efficacy of Rituximab in adults with RRMS.NCT00097188·Phoenix, Arizona and 30 others

CompletedObservational Study of the Prevalence of CCSVI in Multiple Sclerosis and in Other Neurodegenerative DiseasesThe presence of abnormalities in the cerebral venous circulation, defined as Chronic Cerebrospinal Venous Insufficiency (CCSVI), has recently been reported in patients with…NCT01384825·Ancona and 42 others

Active not recruitingA Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple SclerosisThe primary purpose of the study is to evaluate the safety and tolerability of a single-ascending intravenous (IV) dose (Part 1), a single-ascending subcutaneous (SC) dose (Part…NCT05704361·Stanford, California and 25 others

CompletedA Study of Ocrelizumab in Participants With Primary Progressive Multiple SclerosisThis randomized, parallel group, double-blind, placebo controlled study will evaluate the efficacy and safety of ocrelizumab in participants with primary progressive multiple…NCT01194570·Phoenix, Arizona and 183 others

CompletedComparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study OneThe purpose of this study was to establish the efficacy and safety of alemtuzumab (Lemtrada™) as a treatment for relapsing-remitting multiple sclerosis (MS), in comparison with…NCT00530348·Cullman, Alabama and 100 others

CompletedA Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)To evaluate the effectiveness, safety and Patient-Reported Outcomes (PROs) of cladribine tablets in participants with RMS including relapsing-remitting multiple sclerosis (RRMS)…NCT03933202·Cullman, Alabama and 65 others

TerminatedActhar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)This study will enroll about 66 participants who experienced a relapse of RRMS that steroids did not help. The doctor will put participants into a treatment group.NCT03126760·Palo Alto, California and 21 others

TerminatedStudy to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)This is a prospective, multicenter, open-label, single-arm, phase 3b study which evaluates effectiveness and safety of ocrelizumab in participants with early stage RRMS.NCT03085810·Irvine, California and 192 others

Page 1 of 3Next

Other Conditions in San Antonio

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia